首页> 外国专利> USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES

USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN-PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES

机译:使用同种异体细胞系加载抗原呈递细胞以激发或消除免疫反应

摘要

Novel antigen-presenting cells, including but not limited to dendritic cells, that are loaded with antigens from dead or dying cells including allogenic cell lines, and the methods for making such antigen-presenting cells are described. These loaded antigen-presenting cells induce therapeutic immune responses in humans. Such loaded antigen-presenting cells are useful in the management of cancer. Antigen-loaded dendritic cells prepared as described here can prime naïve T cells to differentiate into effector cells able to recognize multiple and/or shared tumor antigens that are expressed either on the tumor cells that are used to load the dendritic cells and/or on other tumor cells. The cytotoxic T cells generated by exposure to antigen-loaded dendritic cells prepared as described here can be used in adoptive therapy. This induction of responses against multiple antigens shared between different cells, for instance tumor cells, as described here is important as it leads to broad immune responses.
机译:描述了新型抗原呈递细胞,其包括但不限于树突状细胞,其装载有来自包括同种异体细胞系的死亡或垂死细胞的抗原,并且描述了制备这种抗原呈递细胞的方法。这些负载的抗原呈递细胞在人体内诱导治疗性免疫应答。这种负载的抗原呈递细胞可用于癌症的治疗。如本文所述制备的负载抗原的树突状细胞可以引发幼稚T细胞分化为效应细胞,该效应细胞能够识别多种和/或共有的肿瘤抗原,这些抗原在负载树突状细胞的肿瘤细胞和/或其他细胞上表达。肿瘤细胞。通过暴露于如本文所述制备的负载抗原的树突细胞中产生的细胞毒性T细胞可用于过继治疗。如本文所述,这种针对在不同细胞(例如肿瘤细胞)之间共享的多种抗原的应答的诱导是重要的,因为它导致广泛的免疫应答。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号